Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V
- PMID: 6804089
Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V
Abstract
Moderate protein malnutrition retarded the i.p. proliferation of L1210 mouse leukemia cells in BALB/c mice. The increased resistance against leukemia cell growth in protein-malnourished mice was correlated with increased in vitro mitogenic responsiveness of spleen lymphocytes to phytohemagglutinin and increased levels of serum corticosterone but could not be correlated with altered development of splenic lymphocyte-mediated cytotoxicity. The increased resistance against leukemia cells in well-fed mice treated with thymosin alone could not be correlated with an increase in any of these parameters. Treatment with Thymosin Fraction V further increased the resistance of protein-malnourished mice to i.p. leukemia cell growth. The increased resistance of these mice to tumor cell growth was correlated with increased splenic lymphocyte mitogenic responsiveness to phytohemagglutinin, elevated serum corticosterone levels, and a slight increase in lymphocyte-mediated cytotoxicity 14 days after tumor challenge. For 7 days after the last treatment, protein-malnourished mice had reduced serum corticosterone levels. Nevertheless, the serum corticosterone levels were still higher than normal in these mice.
Similar articles
-
Thymosin treatment: serum corticosterone and lymphocyte mitogenesis in moderately and severely protein-malnourished mice.J Nutr. 1983 Mar;113(3):483-93. doi: 10.1093/jn/113.3.483. J Nutr. 1983. PMID: 6600784
-
In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.J Immunol. 1981 Feb;126(2):741-4. J Immunol. 1981. PMID: 6161188
-
Manifestation and growth of a transplantable osteosarcoma in mice: the effects of thymectomy and thymosin treatment.Clin Orthop Relat Res. 1981 Sep;(159):279-85. Clin Orthop Relat Res. 1981. PMID: 6974629
-
Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.Cancer Res. 1991 Jan 1;51(1):62-6. Cancer Res. 1991. PMID: 1988107
-
[Modulation of suppressor activity by thymosin].C R Seances Soc Biol Fil. 1981;175(2):235-41. C R Seances Soc Biol Fil. 1981. PMID: 6454471 French.
Cited by
-
Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V.Infect Immun. 1982 Aug;37(2):601-8. doi: 10.1128/iai.37.2.601-608.1982. Infect Immun. 1982. PMID: 6981605 Free PMC article.
-
Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?Vitam Horm. 2016;102:179-207. doi: 10.1016/bs.vh.2016.04.008. Epub 2016 May 27. Vitam Horm. 2016. PMID: 27450735 Free PMC article. Review.
-
Immunomodulation and therapeutic characterization of thymosin fraction five.Cancer Immunol Immunother. 1984;18(3):185-94. doi: 10.1007/BF00205510. Cancer Immunol Immunother. 1984. PMID: 6239686 Free PMC article.
-
Activation of antitumor properties in alveolar macrophages from protein-calorie malnourished rats.Cancer Immunol Immunother. 1986;21(1):63-8. doi: 10.1007/BF00199379. Cancer Immunol Immunother. 1986. PMID: 3080228 Free PMC article.
-
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy.Cancer Immunol Immunother. 2012 May;61(5):599-614. doi: 10.1007/s00262-012-1222-8. Epub 2012 Feb 26. Cancer Immunol Immunother. 2012. PMID: 22366887 Free PMC article. Review.